Side effects are a major reason that drugs are taken off the market and a major reason why patients stop taking their medications, but scientists are now reporting the development of a new way to predict those adverse reactions ...
Other
Jan 2, 2013
1
0
A new stem cell-derived system for screening experimental drugs for cardiotoxicity could identify dangerous side effects early in the development process, thereby potentially saving time, lives and money, according to Evan ...
Cell & Microbiology
Dec 17, 2012
0
0
Two Michigan State University researchers have invented a protein purifier that could help pharmaceutical companies save time and money.
Biochemistry
May 1, 2012
0
0
Traditional drug manufacturing is a time-consuming process. Active pharmaceutical ingredients are synthesized in a chemical manufacturing plant and then shipped to another site, where they are converted into giant batches ...
Other
Mar 12, 2012
0
0
(AP) -- Medical device and drugmaker Abbott Laboratories said Wednesday it will lay off 700 employees as part of ongoing restructuring efforts.
Business
Jan 25, 2012
0
0
There are probably at least 500 medically useful chemicals awaiting discovery in plant species whose chemical constituents have not yet been evaluated for their potential to cure or treat disease, according to a new analysis ...
Other
Dec 12, 2011
2
0
The world's first prototype of a hand-held fingerprint drug testing device has been created by UK technology company Intelligent Fingerprinting.
Engineering
Nov 10, 2011
1
0
A new "organocatalyst" developed at Oregon State University is now available for commercial use. Produced by an Albany, Ore., pharmaceutical company, it should make new drug development around the world less costly, more ...
Materials Science
May 11, 2011
0
0
A prolific University of Missouri chemist has discovered a quicker and easier method for pharmaceutical companies to make certain drugs.
Biochemistry
Mar 8, 2011
0
0
(AP) -- French drug maker Sanofi-Aventis SA has agreed to buy Genzyme Corp. in a sweetened all-cash $20.1 billion deal that ends months of corporate haggling and positions Sanofi at the forefront of the market in lucrative ...
Biotechnology
Feb 16, 2011
0
0
